Age-related macular degeneration (AMD) affects the macula — the small central part of the retina that does the seeing you care about most: faces, print, the road ahead. Its earliest changes are invisible to you, which is exactly why detection and monitoring matter so much.
Dry AMD is by far the more common form. It progresses slowly, often over many years, and many people with it keep useful central vision for life. It requires monitoring, because dry AMD can convert to the wet form.
Wet AMD is less common but far more urgent: abnormal blood vessels grow beneath the macula and can damage central vision within days to weeks. Modern injectable treatments can preserve — sometimes recover — vision, but the results depend heavily on how quickly treatment begins.
Laser imaging (OCT) can reveal the earliest changes of AMD beneath the retina's surface — long before you'd notice anything — and retinal photographs let us compare your macula year over year. For patients with AMD we establish a monitoring schedule matched to their stage, discuss evidence-based nutritional supplementation (the AREDS2 formula) where it's appropriate, and provide an Amsler grid — a simple daily at-home check that can catch new distortion early — along with clear instructions on which changes warrant a call.
If wet AMD is suspected, we arrange prompt referral to a retina specialist for treatment, and continue to coordinate your overall eye care.
Don't smoke; protect your eyes from UV; eat the leafy greens and fish your macula loves; know your family history — and keep your exam schedule, because the treatable window opens before the noticeable one.